Capsid
Graduate Poster
- Joined
- Apr 21, 2004
- Messages
- 1,845
Having successfully developed a vaccine for the SARS would probably be useful for the closely genetically related SARS-CoV-2 (SARS and the new SARS-CoV-2 share about 85 percent of their genetic code).
I was able to read the whole fortune.com article, just by registering (I didn't have to pay anything). I had to wait for a few minutes until their e-mail arrived (only then could I complete the registration by clicking on a link), but this was not necessary for reading the article.
Viral vector vaccines can relatively easily be re- engineered to express the protein of interest. There are adenovirus , Vesicular stomatitis and vaccinia virus platforms that are in development.
Sent from my iPhone using Tapatalk